NEW YORK (GenomeWeb) – AbbVie today announced it is renewing its association with the Structural Genomics Consortium (SGC) for five years with a C$7.5 million (US$5.6 million) cash sponsorship.

The money will be used for open access research to discover new medicines, the firm said in a statement, focusing on chemical tools to explore classes of proteins such as those involved in ion channels, solute carrier channels, and epigenetic regulation.

AbbVie has supported the consortium since 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.